NDC 24338-270 – Vivimusta

Bendamustine Hydrochloride 25 mg/mL · Injection · Intravenous

Human Prescription Drug

Product NDC24338-270

Product details

Brand name
Vivimusta
Generic name
Bendamustine Hydrochloride
Labeler
Azurity Pharmaceuticals, Inc.
Dosage form
Injection
Route
Intravenous
Marketing category
NDA · NDA212209
Marketed since
April 1, 2025
Listing expires
December 31, 2026
Pharmacologic class
Alkylating Drug

Active ingredients

Uses, dosage, side effects and warnings for Vivimusta →

Package NDC codes (1)

Package NDCDescriptionSince
24338-270-011 VIAL, MULTI-DOSE in 1 CARTON (24338-270-01) / 4 mL in 1 VIAL, MULTI-DOSEApr 1, 2025

Other Vivimusta products